The use of molecular volumetric parameters for the evaluation of Lu-177 PSMA I&T therapy response and survival

被引：0
|
作者：
Emine Acar
Özhan Özdoğan
Ayşegül Aksu
Erkan Derebek
Recep Bekiş
Gamze Çapa Kaya
机构：
[1] İzmir Kâtip Çelebi University,Department of Nuclear Medicine, Ataturk Training and Research Hospital
[2] Dokuz Eylul University,Department of Translational Oncology, Institute of Health Sciences
[3] Dokuz Eylul University,Department of Nuclear Medicine, School of Medicine
来源：
Annals of Nuclear Medicine | 2019年 / 33卷
关键词：
PSMA; MTV; TLG; Tumor volume; Precision medicine; Theranostic;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：681 / 688
页数：7
相关论文
共 50 条
  • [21] SUVmean on baseline [18F]PSMA-1007 PET and clinical parameters are associated with survival in prostate cancer patients scheduled for [177Lu]Lu-PSMA I&T
    Philipp E. Hartrampf
    Thomas Hüttmann
    Anna Katharina Seitz
    Hubert Kübler
    Sebastian E. Serfling
    Wiebke Schlötelburg
    Kerstin Michalski
    Steven P. Rowe
    Martin G. Pomper
    Andreas K. Buck
    Uta Eberlein
    Rudolf A. Werner
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 3465 - 3474
  • [22] SUVmean on baseline [18F]PSMA-1007 PET and clinical parameters are associated with survival in prostate cancer patients scheduled for [177Lu]Lu-PSMA I&T
    Hartrampf, Philipp E.
    Huettmann, Thomas
    Seitz, Anna Katharina
    Kuebler, Hubert
    Serfling, Sebastian E.
    Schloetelburg, Wiebke
    Michalski, Kerstin
    Rowe, Steven P.
    Pomper, Martin G.
    Buck, Andreas K.
    Eberlein, Uta
    Werner, Rudolf A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (11) : 3465 - 3474
  • [23] Response assessment using volumetric parameters in mCRPC patients treated with 177 Lu PSMA therapy: A Prognostic yardstick
    Singh, P.
    Nazar, A. H.
    Ora, M.
    Mishra, A.
    Khandelwal, Y.
    Jain, B.
    Mishra, V.
    Pradhan, P. K.
    Gambhir, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S401 - S401
  • [24] Improved therapeutic index with the novel PSMA-ligand 177Lu-rhPSMA-10.1 compared to 177Lu-PSMA I&T - an intrapatient comparison
    Rinscheid, Andreas
    Dierks, Alexander
    Kircher, Malte
    Pfob, Christian
    Wengenmair, Hermann
    Wienand, Georgine
    Lapa, Constantin
    Janzen, Tilman
    Bundschuh, Ralph
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [25] [177LU]LU-PSMA I&T: DEVELOPMENT OF A MULTIPLE-PATIENT DOSE PRODUCTION METHOD
    Walker, A.
    Rivinoja, D.
    Zia, N.
    Seale, J.
    Santamaria, J.
    Santamaria, G.
    Lengkeek, N.
    INTERNAL MEDICINE JOURNAL, 2021, 51 : 35 - 35
  • [26] PBPK Model Based Voxel-wise Prediction of Posttherapy Dosimetry for 177Lu-PSMA I&T Therapy
    Xue, S.
    Gafita, A.
    Drobnjakovic, M.
    Zhao, Y.
    Birindelli, G.
    Afshar-Oromieh, A.
    Eiber, M.
    Rominger, A.
    Shi, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S345 - S346
  • [27] Quantifying the impact of residual activity on therapeutic index: an updated dosimetric comparison between [177Lu]Lu-PSMA-10.1 and [177Lu]Lu-PSMA I&T
    Rinscheid, A.
    Dierks, A.
    Kircher, M.
    Pfob, C.
    Bundschuh, R. A.
    Lapa, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S811 - S812
  • [28] Higher SUV mean in baseline F18-PSMA 1007 PET is associated with longer survival in patients undergoing Radioligand Therapy with [177Lu]Lu-PSMA I&T
    Huettmann, Thomas
    Hartrampf, Philipp
    Seitz, Anna
    Kuebler, Hubert
    Serfling, Sebastian
    Buck, Andreas
    Werner, Rudolf
    Schloetelburg, Wiebke
    Michalski, Kerstin
    Schirbel, Andreas
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [29] Safety and Efficacy of [177Lu]Lu-rhPSMA-10.1 Re-Challenge Therapy in Progressive mCRPC after [177Lu] Lu-PSMA I&T Therapy: Preliminary Results
    Gaeble, A.
    Enke, J.
    Amerein, A.
    Viering, O.
    Rinscheid, A.
    Kircher, M.
    Wienand, G.
    Pfob, C.
    Lapa, C.
    Dierks, A.
    Bundschuh, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S654 - S655
  • [30] Systemic radioligand therapy with 177Lu-PSMA I&T in patients with metastatic castration-resistant prostate cancer
    Eiber, Matthias
    Heck, Matthias
    Tauber, Robert
    Rauscher, Isabel
    D'Alessandria, Calogero
    Maurer, Tobias
    Retz, Margitta
    Wester, Hans
    Schwaiger, Markus
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
12345